Largaespada, David Andrew
- University of Minnesota · Pediatrics (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #6,865
- Rising Star
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pediatrics
NIH Funding · FY2023
Linked Award Amount
$1.3M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#6,865
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Largaespada, David Andrew as a PI. Multi-PI records show the full award amount for context.
- 5UH3CA244687-05UH3Contact PIRecurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor ImmunopreventionUniversity of Minnesota · Pediatrics (NIH department code)$770Kaward amount
- 5R01NS115438-04R01Contact PIUncovering treatment targets for peripheral nerve sheath tumor progression in NF1University of Minnesota · Pediatrics (NIH department code)$571.8Kaward amount
Award organization
Organizations that administered FY2023 awards listing Largaespada, David Andrew as a PI.
FY2023 award administered by University of Minnesota (MN).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardUniversity of Minnesota
- 2007$500K Cumulative Funding
- 2008$1M Cumulative Funding
- 2012$2M Cumulative Funding
- 2012R01 Grant Holder
- 2014Entered Top 50% NationallyRanked #7644
- 2016$5M Cumulative Funding
- 2023$10M Cumulative Funding